CDKN2A and hepatocellular carcinoma: Indeed, aberrant DNA methylation, specifically p16INK4A methylation, is frequently detected in patients with HCV-related liver diseases such as chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC) [111].